Bleeding risk factors and real-world antithrombotic therapies in elderly patients with atrial fibrillation undergoing percutaneous coronary intervention: a retrospective study
Kanako Fujita, Noriko Kohyama, Miki Sato, Tomokazu Deguchi, Hiroshi Suzuki, Mio Ebato, Mari Kogo · 2023
Read Bleeding risk factors and real-world antithrombotic therapies in elderly patients with atrial fibrillation undergoing percutaneous coronary intervention: a retrospective study by Kanako Fujita, Noriko Kohyama, Miki Sato, Tomokazu Deguchi, Hiroshi Suzuki, Mio Ebato, Mari Kogo (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10714450.txt.
Description
Kanako Fujita and co-authors identify what raises bleeding risk in older heart patients treated with artery stents, in this 2023 study. The patients had atrial fibrillation, so they take blood thinners that themselves raise bleeding risk. The team reviewed one hundred thirty-four elderly patients treated at one Japanese hospital.
Bleeding events struck about thirty-one percent of patients within a year. Age over eighty, disease in several vessels, and a past surgery each raised the odds of bleeding roughly threefold. Patients on three blood-thinning drugs bled far more often than others. The authors urge matching drug intensity to each patient's risk profile. Their factors give clinics a practical checklist before treatment.
Catalog record
| CREATOR | Kanako Fujita, Noriko Kohyama, Miki Sato, Tomokazu Deguchi, Hiroshi Suzuki, Mio Ebato, Mari Kogo |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |